Online sessions on process and operational intelligence, PAT, cleanroom qualification, data integrity, and more.

2020 Bio/Pharma Virtual Congress: November 11, 2020

The manufacture of gene therapy vectors is shifting to more modern technologies.

Bioprocessing for Gene Therapy Viral Vectors

The set-up and optimization of a loss-in-weight feeder is demonstrated. 

Loss-in-Weight Feeding of Poorly Flowing Materials

Topic

Articles

Two FDA-funded projects at RCPE will look at real-time monitoring and control of drug tablet coating and developing a digital twin for drug production control.

RCPE Awarded FDA Funding to Develop Next-Generation Technology

Catalent has signed an agreement with Bone Therapeutics for the acquisition of Skeletal Cell Therapy Support SA (SCTS).

Catalent Acquires Bone Therapeutics’ Cell Manufacturing Facility 

3P Biopharmaceuticals, and Oxford University spin-out, SpyBiotech, have signed a vaccine contract manufacturing agreement.

3P Biopharmaceuticals and SpyBiotech Sign Vaccine Manufacturing Agreement

The Phase III clinical trial of NVX-CoV2373 is expected to be fully enrolled in the UK and will begin in the US and Mexico by the end of November 2020.

Novavax COVID-19 Vaccine Trial Expands Enrollment

The CountQ system from Verista automates accurate counts of tray-loaded parts, including vaccine vials. 

Inspection and Reconciliation Machine Accurately Counts Tray Loads

Edge-AI technology will enable Industry 4.0 automation in pharmaceutical manufacturing.

Neurala Partners with IMA Group on AI for Manufacturing Automation

Automation, digitalization, and supply-chain strategies help mitigate vulnerabilities in both autologous and allogeneic cell therapy manufacturing.

Navigating Cell Therapy Manufacturing Amid Pandemic Woes

Jennifer Markarian is manufacturing editor of BioPharm International.

Automation and tools for remote monitoring are finding increased use as pharmaceutical manufacturing adapts to pandemic restrictions. 

Pandemic Drives Digitalization in Bio/Pharma Manufacturing

The company’s new closed cell therapy processing system enables scalable, cost-effective development and manufacturing of cell therapies.

Thermo Fisher Scientific Launches Closed System for Cell Therapy Manufacturing

The new VirusExpress lentiviral production platform increases dose yields and reduces process development time for cell and gene therapies.

MilliporeSigma Launches Lentiviral Production Platform for Cell and Gene Therapies

Aseptic/Sterile Processing

Cleanroom Equipment and Supplies

Clinical Trial Materials

Equipment

Facility Design and Engineering

Fill-Finish

Information Technology

Manufacturing Equipment, Biologics

Manufacturing Equipment, Downstream Processing

Manufacturing Equipment, Fill-Finish

Manufacturing Equipment, Solid Dose Drugs

Manufacturing Equipment, Upstream Processing

Manufacturing Services

Manufacturing Systems, Single-Use

Manufacturing, Biologic Drugs

Manufacturing, Biosimilars and Biobetters

Manufacturing, Cell Culture and Fermentation

Manufacturing, Cell Therapies

Manufacturing, Cell-Line Selection

Manufacturing, Combination Drugs

Manufacturing, Continuous Solid Dosage Processing

Manufacturing, Drug Products

Manufacturing, Expression Systems

Manufacturing, Gene Therapies

Manufacturing, Inhalation Drugs

Manufacturing, Liquid Drug Products

Manufacturing, Lyophilization

Manufacturing, Nucleic Acids

Manufacturing, Parenterals and Injectables

Manufacturing, Process Chromatography

Manufacturing, Recombinant Proteins

Manufacturing, Separation and Purification

Manufacturing, Solid Dosage Drugs

Manufacturing, Specialty Dosage Forms

Manufacturing, Topical Drugs

Manufacturing, Vaccines

Packaging Trends

Packaging, Labeling, and Distribution Systems

PharmTech Products

Process Control, Automation, and PAT

Supply Chain

Technology Transfer

Viral Clearance

Manufacturing